![]() |
Consortium Publications |
|||
|
Gill DR, Smyth SE, Goddard CA, Pringle IA, Higgins CF,
Colledge WH, Hyde SC. Increased persistence of lung gene expression using
plasmids containing the ubiquitin C or elongation factor 1alpha promoter.
Gene Ther. 2001 Oct;8(20):1539-46. Davies JC, Geddes DM, Alton EW. Gene therapy for cystic fibrosis. J Gene Med. 2001 Sep-Oct;3(5):409-17. View Abstract Ferrari S, Kitson C, Farley R, Steel R, Marriott C, Parkins DA, Scarpa M, Wainwright B, Evans MJ, Colledge WH, Geddes DM, Alton EW. Mucus altering agents as adjuncts for nonviral gene transfer to airway epithelium. Gene Ther. 2001 Sep;8(18):1380-6. View Abstract Griesenbach U, Alton EW. Recent
progress in gene therapy for cystic fibrosis.
Curr Opin Mol Ther.
2001 Aug;3(4):385-9.
Davies JC, Geddes DM, Alton EW.
Prospects for gene therapy in lung disease.
Curr Opin Pharmacol.
2001 Jun;1(3):272-7.
Scheid P, Kempster L, Griesenbach U, Davies JC, Dewar A,
Weber PP, Colledge WH, Evans MJ, Geddes DM, Alton EW. Inflammation in
cystic fibrosis airways: relationship to increased bacterial adherence. Eur
Respir J. 2001 Jan;17(1):27-35. |
||||